Skip to content

PTHS PTHS Change in AR

Change in AR at other companies

Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
-$2.68M-121%
Scilex Holding Company logo
Scilex Holding CompanySCLX
-$4.6M+70.9%
Journey Medical Corporation logo
Journey Medical CorporationDERM
-$4.76M-160%
Opko Health logo
Opko HealthOPK
-$9.53M+58.5%
HRO
HarrowHROW
-$9.83M+74.9%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$6.3M+12.1%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+92.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's change in AR?
PTHS (PTHS) reported change in AR of $2.84M in Q1 2026.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.